These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7783128)

  • 61. Actions of potassium channel openers in rat detrusor urinae.
    Ha JH; Lee KY; Kim WJ
    J Korean Med Sci; 1993 Feb; 8(1):53-9. PubMed ID: 8343221
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparative effects of the K+ channel openers, pinacidil and cromakalim on vascular tone: sensitivity to glyburide and calcium.
    Triggle CR; Li YQ; Wyse DG
    Proc West Pharmacol Soc; 1992; 35():97-102. PubMed ID: 1502246
    [No Abstract]   [Full Text] [Related]  

  • 63. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers.
    Cho H; Katoh S; Sayama S; Murakami K; Nakanishi H; Kajimoto Y; Ueno H; Kawasaki H; Aisaka K; Uchida I
    J Med Chem; 1996 Sep; 39(19):3797-805. PubMed ID: 8809167
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 3-Alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel openers: effect of 6,7-disubstitution on potency and tissue selectivity.
    de Tullio P; Boverie S; Becker B; Antoine MH; Nguyen QA; Francotte P; Counerotte S; Sebille S; Pirotte B; Lebrun P
    J Med Chem; 2005 Jul; 48(15):4990-5000. PubMed ID: 16033278
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect on K(ATP) channel activation properties and tissue selectivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides.
    Boverie S; Antoine MH; Somers F; Becker B; Sebille S; Ouedraogo R; Counerotte S; Pirotte B; Lebrun P; de Tullio P
    J Med Chem; 2005 May; 48(10):3492-503. PubMed ID: 15887958
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of adenosine-triphosphate-sensitive potassium channels in the mechanical responses of agonist-stimulated isolated porcine coronary arteries.
    Nguyen DH
    Arzneimittelforschung; 1997 Dec; 47(12):1351-8. PubMed ID: 9450163
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Toward tissue-selective pancreatic B-cells KATP channel openers belonging to 3-alkylamino-7-halo-4H-1,2,4-benzothiadiazine 1,1-dioxides.
    de Tullio P; Becker B; Boverie S; Dabrowski M; Wahl P; Antoine MH; Somers F; Sebille S; Ouedraogo R; Hansen JB; Lebrun P; Pirotte B
    J Med Chem; 2003 Jul; 46(15):3342-53. PubMed ID: 12852765
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential sensitivity to ATP-sensitive potassium channel openers of norepinephrine-induced contraction of guinea pig and rat aorta.
    Saito W; Aida M; Sasaki M; Saito Y; Tanaka Y; Tanaka H; Shigenobu K
    Life Sci; 1998; 62(24):2171-9. PubMed ID: 9627075
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Relaxation by cromakalim and pinacidil of isolated smooth muscle cells from canine coronary artery-multiple sites of action.
    Rhim BY; Hong KW
    Arch Int Pharmacodyn Ther; 1994; 328(1):67-81. PubMed ID: 7893192
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of cromakalim, RP49356, diazoxide, glibenclamide and galanin in rat portal vein.
    Longmore J; Newgreen DT; Weston AH
    Eur J Pharmacol; 1990 Nov; 190(1-2):75-84. PubMed ID: 1706274
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Activation of ATP-sensitive K+ channels by cromakalim. Effects on cellular K+ loss and cardiac function in ischemic and reperfused mammalian ventricle.
    Venkatesh N; Stuart JS; Lamp ST; Alexander LD; Weiss JN
    Circ Res; 1992 Dec; 71(6):1324-33. PubMed ID: 1423930
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Vascular pharmacology of ATP-sensitive K+ channels: interactions between glyburide and K+ channel openers.
    Meisheri KD; Khan SA; Martin JL
    J Vasc Res; 1993; 30(1):2-12. PubMed ID: 8435468
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification and properties of an ATP-sensitive K+ current in rabbit sino-atrial node pacemaker cells.
    Han X; Light PE; Giles WR; French RJ
    J Physiol; 1996 Jan; 490 ( Pt 2)(Pt 2):337-50. PubMed ID: 8821133
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Potassium channel-opening and vasorelaxant profiles of a novel compound YM099 in rat isolated portal vein and rabbit isolated aorta.
    Uchida W; Hirano Y; Shirai Y; Taguchi T; Masuda N; Shibasaki K; Hirano S; Matsumoto Y; Tsuzuki R; Yanagisawa I
    Arch Int Pharmacodyn Ther; 1994; 327(3):330-43. PubMed ID: 7848015
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
    Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
    J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Changes in cardiac resistance to arrhythmogenic effects during ATP-dependent K+ channel activation].
    Bogomaz SA; Maslov LN; Krylatov AV; Solenkova NV; Lishmanov AIu; Budankova EV; Grover GJ
    Ross Fiziol Zh Im I M Sechenova; 2003 Apr; 89(4):409-19. PubMed ID: 12966718
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Novel potassium-channel openers: preparation and pharmacological evaluation of racemic and optically active N-(6-amino-3-pyridyl)-N'-bicycloalkyl-N"-cyanoguanidine derivatives.
    Eda M; Takemoto T; Ono S; Okada T; Kosaka K; Gohda M; Matzno S; Nakamura N; Fukaya C
    J Med Chem; 1994 Jun; 37(13):1983-90. PubMed ID: 8027980
    [TBL] [Abstract][Full Text] [Related]  

  • 78. KCO912: a potent and selective opener of ATP-dependent potassium (K(ATP)) channels which suppresses airways hyperreactivity at doses devoid of cardiovascular effects.
    Buchheit KH; Manley PW; Quast U; Russ U; Mazzoni L; Fozard JR
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):220-30. PubMed ID: 11882918
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Is there a therapeutic future for "potassium channel openers'?
    Lawson K
    Clin Sci (Lond); 1996 Dec; 91(6):651-63. PubMed ID: 8976800
    [TBL] [Abstract][Full Text] [Related]  

  • 80. KATP-channel openers protect against increased cytosolic calcium during ischaemia and reperfusion.
    Behling RW; Malone HJ
    J Mol Cell Cardiol; 1995 Sep; 27(9):1809-17. PubMed ID: 8523442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.